Endogenous opioid release in the human brain reward system induced by acute amphetamine administration.
about
State-dependent μ-opioid modulation of social motivationThe Neurobiology Shaping Affective Touch: Expectation, Motivation, and Meaning in the Multisensory ContextApplication of cross-species PET imaging to assess neurotransmitter release in brainThe Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.Pleasure systems in the brainResponse of the μ-opioid system to social rejection and acceptanceIt still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder.In vivo imaging of cerebral dopamine D3 receptors in alcoholism.Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.Effects of amphetamine on the human brain opioid system--a positron emission tomography study.Neuroscience of affect: brain mechanisms of pleasure and displeasure.Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers.Regional brain [(11)C]carfentanil binding following tobacco smoking.The detrimental effects of emotional process dysregulation on decision-making in substance dependence.Two-hit exposure to polychlorinated biphenyls at gestational and juvenile life stages: 2. Sex-specific neuromolecular effects in the brain.Neural vulnerability factors that increase risk for future weight gain.Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological GamblersReduced pain perception in children and adolescents with ADHD is normalized by methylphenidate.β-Arrestin 2 knockout mice exhibit sensitized dopamine release and increased reward in response to a low dose of alcohol.Mu-opioid stimulation in rat prefrontal cortex engages hypothalamic orexin/hypocretin-containing neurons, and reveals dissociable roles of nucleus accumbens and hypothalamus in cortically driven feeding.Interoception and drug addictionAnhedonia revisited: is there a role for dopamine-targeting drugs for depression?The role of the opioid system in alcohol dependence.Optimising PET approaches to measuring 5-HT release in human brain.Prefrontal Cortical Opioids and Dysregulated Motivation: A Network Hypothesis.Opioid Modulation of Value-Based Decision-Making in Healthy Humans.Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids.Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalization.Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity.Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates.Amphetamine induced endogenous opioid release in the human brain detected with [¹¹C]carfentanil PET: replication in an independent cohort.Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.Sensitivity of [(11)C]ORM-13070 to increased extracellular noradrenaline in the CNS - a PET study in human subjects.Acute naltrexone does not remediate fronto-striatal disturbances in alcoholic and alcoholic polysubstance-dependent populations during a monetary incentive delay task.Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the alpha2C-adrenoceptor PET ligand [11C]ORM-13070.Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individualsA preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder
P2860
Q22305623-3820EB18-2F33-4D97-9464-2AEF870E6F83Q26771487-3926C027-FEB9-46D4-BFC2-81119C3E4008Q26865012-4DF76965-07BB-4B19-99E2-ACD2CC730E16Q27310644-0F325486-34BE-4D09-854D-ED247BCD4E29Q28261680-249C044B-E9C5-4811-8D56-ABAF60CF3D67Q30556368-2F9FCBEE-CEE1-42B3-B423-B391D2DE0721Q30654561-95437288-C026-4663-86D4-FA9CDB16BDA0Q33620597-4936DB23-A35F-45C3-A54F-B2B834591F57Q33635733-7A90981D-10A8-483A-92B6-E78483CAF2C4Q34296653-C05039A5-602C-421B-A63A-AF9022D79EDCQ34325761-04A5FF63-2F47-4707-8024-8CC4DF42292FQ34671636-FA07D72D-57E6-4E6F-BA1E-86C34AFEEA53Q35222619-991E61BA-FDF1-4485-B99F-A1769048590CQ36377851-F7A244B9-703E-4FD2-83F3-F2930D18B678Q36437130-E81277CD-9787-4296-918F-E8B1B21AD1EBQ36777473-7A6A1FCB-5579-4C35-BC1E-385EE70BBA38Q36906636-49BD8813-CE57-47F1-980A-8B9781298EA4Q37118184-8EEDFEFA-458F-4857-9899-D537DACFE139Q37281047-FD1CF78D-C4F5-4551-ACD0-96D110DB38ECQ37325389-AB817FEC-BA90-436D-B292-9A6A6D5D68F8Q37381307-709E185D-AD50-4101-9740-E5363FBE008BQ38125667-2C8783BE-9651-4C2C-A71F-460B02A27330Q38139197-CE6C88DB-E39A-4111-A42C-562A81D14FA2Q38531787-9CE669E7-D060-4F85-B62C-04CE2F1258A3Q38846230-8F4C76B5-A45F-4A5A-B038-E6D5A4C4C668Q38907715-4D05C312-952D-48CF-BD75-C41CB23EFB5FQ39155830-AA92FB4A-1961-4C4C-971B-5A0E83A9CAF5Q43069916-8B0B3FCC-3E73-4A19-9510-A585A8197DD6Q43578699-572CE60A-65A8-4DBF-BAFA-5E0771EFDF31Q44255978-2B34445C-0F11-467F-BB89-6089219A718EQ44344726-E93CDAC9-C277-4E81-BEF7-2F9BFAC16F1EQ44347361-35161742-E34E-4CF5-A35B-1BB07A3B5472Q48206466-3288FA99-E0D8-41B2-97AC-6E2428298B80Q48528099-23D01383-1077-4D92-B4EA-E5C1AECF07D0Q52146902-9AC40F10-E0E2-426E-9441-29E2E01ACF81Q56967254-CC1C621D-073B-4CCD-BA76-8E98C4B7332FQ58702818-A3CCAB61-B4E3-43FB-A402-89D17F0BAD54
P2860
Endogenous opioid release in the human brain reward system induced by acute amphetamine administration.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Endogenous opioid release in t ...... te amphetamine administration.
@ast
Endogenous opioid release in t ...... te amphetamine administration.
@en
Endogenous opioid release in t ...... te amphetamine administration.
@nl
type
label
Endogenous opioid release in t ...... te amphetamine administration.
@ast
Endogenous opioid release in t ...... te amphetamine administration.
@en
Endogenous opioid release in t ...... te amphetamine administration.
@nl
prefLabel
Endogenous opioid release in t ...... te amphetamine administration.
@ast
Endogenous opioid release in t ...... te amphetamine administration.
@en
Endogenous opioid release in t ...... te amphetamine administration.
@nl
P2093
P50
P1476
Endogenous opioid release in t ...... te amphetamine administration.
@en
P2093
Andri C Tziortzi
Anne R Lingford-Hughes
Christopher J Long
Darren Quelch
Graham E Searle
Koen R J Schruers
Laurence J Reed
Richard R Reiley
Samuel P Hill
P304
P356
10.1016/J.BIOPSYCH.2012.01.027
P407
P50
P577
2012-03-03T00:00:00Z